Chongqing Zhifei Biological Products Co.,Ltd provided earnings outlook for the nine months ended September 30, 2014. For the period, the company expects net profit attributable to shareholders is to be CNY 144.6812 million, rising zero to 10% from a year earlier.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.08 CNY | +0.08% |
|
-5.58% | -57.32% |
Jun. 19 | Chongqing Zhifei Biological Products Co., Ltd. Approves Cash Dividend for the Year 2023 | CI |
Apr. 23 | Chongqing Zhifei Biological Products' 2023 Profit Rises 7%; Shares Plunge 12% | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.32% | 8.58B | |
+3.84% | 97.02B | |
+4.74% | 40.94B | |
-11.48% | 33.35B | |
+81.62% | 29.53B | |
-13.94% | 15.76B | |
-3.33% | 13.65B | |
-12.64% | 11.44B | |
+166.50% | 10.08B | |
+4.79% | 9.06B |
- Stock Market
- Equities
- 300122 Stock
- News Chongqing Zhifei Biological Products Co., Ltd.
- Chongqing Zhifei Biological Products Co.,Ltd Provides Earnings Outlook for the Nine Months Ended September 30, 2014